Inhibrx Biosciences, Inc.
US ˙ NasdaqGS ˙ US45720L1070

SecurityINBX / Inhibrx Biosciences, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership12,366 shares
Latest Disclosed Value $ 166,570
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.49% increase in ownership of INBX / Inhibrx Biosciences, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 12,366 shares of Inhibrx Biosciences, Inc. (US:INBX) valued at $166,570 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 12,306 shares of Inhibrx Biosciences, Inc.. This represents a change in shares of 0.49% during the quarter. The current value of the position is $1,075,966 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP INHIBRX BIOSCIENCES EC US45720N1037 12,366 60 0.49 167 1.84 0.0022
2025-04-25 2025-02-28 NP INHIBRX BIOSCIENCES EC US45720N1037 12,306 324 2.70 163 -10.44 0.0022
2025-01-27 2024-11-30 NP INHIBRX BIOSCIENCES EC US45720N1037 11,982 84 0.71 183 5.20 0.0025
2024-10-29 2024-08-31 NP INHIBRX BIOSCIENCES EC US45720N1037 11,898 11,667 5,050.65 173 5,666.67 0.0026
2024-07-26 2024-05-31 NP INHIBRX BIOSCIENCES EC US45720N1037 231 -18,906 -98.79 4 -99.57 0.0001
2024-04-24 2024-02-29 NP INHIBRX EC US45720L1070 19,137 310 1.65 701 79.03 0.0117
2024-01-24 2023-11-30 NP INHIBRX EC US45720L1070 18,827 30 0.16 391 -2.74 0.0075
2023-10-27 2023-08-31 NP INHIBRX EC US45720L1070 18,797 10,161 117.66 402 97.06 0.0079
2023-07-26 2023-05-31 NP INHIBRX EC US45720L1070 8,636 24 0.28 204 -1.45 0.0044
2023-04-27 2023-02-28 NP INHIBRX EC US45720L1070 8,612 180 2.13 207 -17.86 0.0051
2023-01-26 2022-11-30 NP INHIBRX EC US45720L1070 8,432 -5,847 -40.95 253 35.48 0.0063
2022-07-29 2022-05-31 NP INHIBRX EC US45720L1070 14,279 416 3.00 187 -37.58 0.0048
2022-04-28 2022-02-28 NP INHIBRX EC US45720L1070 13,863 -11,555 -45.46 298 -70.98 0.0069
2022-01-25 2021-11-30 NP INHIBRX EC US45720L1070 25,418 688 2.78 1,028 45.67 0.0215
2021-10-26 2021-08-31 NP INHIBRX EC US45720L1070 24,730 6,466 35.40 705 82.64 0.0155
2021-07-22 2021-05-31 NP INHIBRX EC US45720L1070 18,264 7,773 74.09 386 45.11 0.0096
2021-04-23 2021-02-28 NP INHIBRX EC US45720L1070 10,491 10,491 267 0.0069
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.